Lantern Pharma
LTRN
LTRN
39 hedge funds and large institutions have $6.01M invested in Lantern Pharma in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
38% less capital invested
Capital invested by funds: $9.75M → $6.01M (-$3.75M)
Holders
39
Holding in Top 10
–
Calls
$309K
Puts
$26K
Top Buyers
| 1 | +$298K | |
| 2 | +$162K | |
| 3 | +$159K | |
| 4 |
BlackRock
New York
|
+$94.3K |
| 5 |
Renaissance Technologies
New York
|
+$75.2K |
Top Sellers
| 1 | -$220K | |
| 2 | -$219K | |
| 3 | -$101K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$15.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.42K |